V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 290004598 | 290003368 | 1.55 | 53 | Palliative (P) | 2014-10-08 | 2014-10-16 | CISPLATIN + FLUOROURACIL | N | N | 290021466 | OCTREOTIDE |
| 290004599 | 290003369 | null | 93.5 | Neo-adjuvant (N) | 2013-10-04 | 2013-10-04 | Cetuximab 7 day (Cycle 1) | 02 | null | 290021472 | CISPLATIN + ETOPOSIDE |
| 290004600 | 290003370 | 1.67 | 0 | Curative (C) | 2013-02-25 | 2013-02-26 | Ralitrexed | 1 | N | 290021473 | PACLITAXEL |
| 290004601 | 290003371 | null | 63 | Adjuvant (A) | 2014-01-05 | 2014-01-23 | Cisplatin +Fluorouracil (3 wk) | 02 | N | 290021474 | IRINOTECAN + MDG |
| 290004602 | 290003372 | 1.55 | null | Palliative (P) | null | 2014-09-04 | OCTREOTIDE | N | N | 290021475 | CETUXIMAB + RT |
| 290004603 | 290003373 | 1.8 | 53.4 | Palliative (P) | 2014-05-19 | 2014-06-06 | Cetuximab +Cisplatin + FU (Cycle 1) | N | N | 290021476 | CAPECITABINE |
| 290004604 | 290003374 | null | null | Curative (C) | 2015-07-12 | 2015-07-21 | Capecitabine + Streptozocin | N | N | 290021478 | CAPECITABINE |
| 290004605 | 290003375 | null | 77.8 | Adjuvant (A) | 2013-09-09 | 2013-10-11 | Pemetrexed | N | Y | 290021479 | CAPECITABINE + RT |
| 290004606 | 290003376 | 1.57 | 61 | Palliative (P) | 2016-10-20 | 2016-11-06 | LANREOTIDE | N | N | 290021480 | CARBOPLATIN + PACLITAXEL |
| 290004607 | 290003376 | 1.71 | 110 | Palliative (P) | 2016-03-22 | 2016-03-30 | Sorafenib | 2 | N | 290021480 | CISPLATIN + FLUOROURACIL |
| 290004608 | 290003377 | 1.61 | 63 | Adjuvant (A) | 2016-12-06 | 2016-12-10 | CAP + RT | N | N | 290021482 | BALLAD TRIAL |
| 290004609 | 290003378 | 1.68 | 96.8 | Palliative (P) | 2015-08-01 | 2015-08-12 | CETUXIMAB + RT | N | N | 290021483 | CAPECITABINE + RT |
| 290004610 | 290003379 | 0 | 79 | Palliative (P) | 2015-10-16 | 2015-11-15 | Ipilimumab | N | N | 290021484 | CAPECITABINE + CISPLATIN |
| 290004611 | 290003380 | 2 | 50 | Adjuvant (A) | 2015-11-29 | 2015-12-03 | Cisplatin + Docetaxel +Fluorouracil | N | N | 290021485 | CARBOPLATIN |
| 290004612 | 290003381 | 1.6 | 64.5 | Palliative (P) | 2017-11-05 | 2017-11-09 | Cisplatin + Docetaxel +Fluorouracil | N | N | 290021486 | CARBOPLATIN |
| 290004613 | 290003381 | null | null | Palliative (P) | 2017-09-04 | 2017-09-09 | FLUOROURACIL + RT | N | N | 290021486 | LANREOTIDE |
| 290004614 | 290003382 | 1.79 | null | Palliative (P) | null | 2015-08-31 | Cisplatin + Gemcitabine (D 1 & 8) | null | null | 290021488 | EOX |
| 290004618 | 290003384 | 1.63 | 88.9 | Palliative (P) | 2017-07-02 | 2017-07-02 | Dacarbazine | 02 | null | 290021494 | GEMCARBO |
| 290004619 | 290003385 | 1.6 | 95 | Curative (C) | 2017-05-14 | 2017-06-10 | Carboplatin + Etoposide IV 3 day | N | Y | 290021495 | AZACITIDINE |
| 290004620 | 290003386 | 1.78 | null | Palliative (P) | null | 2019-02-22 | Capecitabine | null | N | 290021496 | CAPECITABINE + RT |
| 290004621 | 290003387 | null | 97.2 | Curative (C) | 2013-09-12 | 2013-10-10 | LANREOTIDE | N | Y | 290021497 | ECX |
| 290004622 | 290003388 | 1.59 | 61.4 | Curative (C) | 2014-11-04 | 2014-11-07 | PLATO Trials | N | N | 290021499 | CARBOPLATIN + RT |
| 290004623 | 290003388 | 1.8 | 97.8 | Palliative (P) | 2017-08-27 | 2017-09-07 | Capecitabine | N | N | 290021499 | EVEROLIMUS |
| 290004625 | 290003390 | 1.75 | 69.8 | Palliative (P) | 2016-03-29 | 2016-03-29 | LANREOTIDE | 2 | N | 290021504 | BENDAMUSTINE + RITUXIMAB |
| 290004626 | 290003391 | 1.68 | 86.1 | Palliative (P) | 2014-06-12 | 2014-06-12 | CAPECITABINE + CETUXIMAB + IRINOTECAN | N | N | 290021507 | GEMCARBO |
| 290004627 | 290003392 | null | 69.3 | Adjuvant (A) | 2015-06-26 | 2015-07-17 | Capecitabine | N | Y | 290021510 | ECX |
| 290004628 | 290003392 | 1.74 | 86 | Palliative (P) | 2015-12-05 | 2015-12-28 | Fluorouracil + Folinic Acid Weekly | N | N | 290021510 | CETUXIMAB |
| 290004629 | 290003393 | 1.6 | 78.9 | Palliative (P) | 2016-04-09 | 2016-04-21 | Capecitabine | N | N | 290021515 | CAPECITABINE + CISPLATIN |
| 290004630 | 290003394 | 1.58 | 62.7 | Neo-adjuvant (N) | 2014-11-19 | 2014-11-27 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | N | 290021518 | LANREOTIDE |
| 290004631 | 290006521 | 1.84 | 82 | Palliative (P) | 2015-12-12 | 2015-12-17 | Irinotecan + Modified De Gramont | 02 | N | 290021519 | GEMCITABINE |
| 290004632 | 290003395 | null | 79.5 | Palliative (P) | 2015-06-16 | 2015-06-16 | CAPECITABINE + GEMCITABINE | 02 | N | 290021522 | OCTREOTIDE |
| 290004633 | 290003396 | 1.61 | 74.6 | Curative (C) | 2013-11-28 | 2013-12-20 | Capecitabine | N | N | 290021526 | CAPECITABINE |
| 290004634 | 290003397 | null | 60 | Adjuvant (A) | 2015-07-18 | 2015-07-19 | LANREOTIDE | 2 | N | 290021527 | LANREOTIDE |
| 290004635 | 290003397 | 1.59 | 47.2 | Not known (9) | 2015-07-06 | 2015-08-02 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 2 | Y | 290021527 | CETUXIMAB + RT |
| 290004636 | 290003397 | 1.74 | 84 | Palliative (P) | 2015-03-19 | 2015-03-20 | Capecitabine | N | N | 290021527 | CARBOPLATIN + DOCETAXEL + FLUOROURACIL |
| 290004637 | 290003398 | 1.65 | 71.3 | Palliative (P) | 2019-02-26 | 2019-03-12 | CETUXIMAB + RT | 02 | N | 290021532 | CARBOPLATIN + CETUXIMAB + FU |
| 290004638 | 290003399 | 1.6 | null | null | 2016-05-09 | 2016-05-28 | EOX | 02 | N | 290021533 | CETUXIMAB + RT |
| 290004639 | 290003400 | 0 | 30.2 | Curative (C) | 2017-05-10 | 2017-05-29 | OCTREOTIDE | N | Y | 290021535 | AZACITIDINE |
| 290004640 | 290003400 | 0 | 83.1 | Palliative (P) | 2016-06-16 | 2016-06-22 | Capecitabine 35days + RT | 02 | N | 290021535 | EOX |
| 290004641 | 290003401 | 1.5 | 61.8 | Disease modification (D) | null | 2016-10-01 | EOX | N | N | 290021537 | CAPECITABINE |
| 290004642 | 290003402 | 1.6 | 53.6 | null | 2017-05-31 | 2017-06-01 | Cetuximab 7 day (Cycle 1) | 02 | N | 290021540 | TRIAL |
| 290004643 | 290003403 | 1.55 | 57 | Adjuvant (A) | 2017-01-19 | 2017-01-30 | Cisplatin + Docetaxel +Fluorouracil | N | N | 290021541 | GEMCITABINE |
| 290004644 | 290003403 | 1.7 | 54.2 | Curative (C) | 2016-09-07 | 2016-09-20 | Fluorouracil 96hr infusion+R(4g/m2) | 02 | null | 290021541 | CAPECITABINE + RT |
| 290004645 | 290003403 | 1.62 | 75.7 | Palliative (P) | 2018-02-14 | 2018-02-16 | Paclitaxel 80mg/m2 day 1 8 15 | 2 | null | 290021541 | CISPLATIN + FLUOROURACIL |
| 290004646 | 290003403 | 1.62 | 108 | Palliative (P) | 2013-09-01 | 2014-02-15 | LANREOTIDE | N | N | 290021541 | CHOP R |
| 290004647 | 290003403 | 1.61 | 65.2 | Palliative (P) | 2017-08-26 | 2017-09-12 | Cisplatin + Docetaxel +Fluorouracil | 2 | N | 290021541 | CAPECITABINE + RT |
| 290004648 | 290003404 | 1.77 | 95.3 | null | 2016-04-24 | 2016-05-15 | Capecitabine | 02 | N | 290021548 | CISPLATIN + FLUOROURACIL |
| 290004649 | 290006525 | 1.7 | 74.1 | Curative (C) | 2014-03-17 | 2014-04-07 | EOX | N | Y | 290021549 | CARBOPLATIN + RT |
| 290004650 | 290006525 | 1.69 | 96.5 | Curative (C) | null | 2014-05-07 | Cisplatin + Etoposide po&iv 3 day | N | Y | 290021549 | CISPLATIN + FLUOROURACIL |
| 290004651 | 290003405 | 1.64 | 78.9 | Palliative (P) | null | 2014-01-14 | CHOP - 21 days | null | N | 290021554 | CAPECITABINE + RT |